-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024004-bajaj-final-report-2017.pdf
January 01, 2017 - analysis were age, gender, alcoholic
etiology, HE prior to admission, admission MELD (model for end-stage liver … hydrothorax (n=1),
upper GI bleeding (n=2), chest pain (n=1), anemia (n=1), opioid overdose (n=1), liver … Poster
Presentation at International Liver Congress at EASL 2017 Amsterdam.
2. … Accepted article in Liver International (accepted 6.7.17 no citation available as of today)
The Patient
-
hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR-ChangeLog-v20241-v20251.xlsx
November 01, 2024 - approach, hand-assisted HEP004 Hepatobiliary resection and ablation
0FB14ZG Excision of right lobe liver … approach, hand-assisted HEP004 Hepatobiliary resection and ablation
0FB24ZG Excision of left lobe liver … or Artificial Opening Endoscopic HEP010 Hepatobiliary and pancreatic drainage
0FT04ZG Resection of liver … approach, hand-assisted HEP004 Hepatobiliary resection and ablation
0FT14ZG Resection of right lobe liver … approach, hand-assisted HEP004 Hepatobiliary resection and ablation
0FT24ZG Resection of left lobe liver
-
psnet.ahrq.gov/web-mm/toxic-tachycardia
March 01, 2005 - Liver function test abnormalities are not uncommon ( 4 ), and diffuse abdominal pain and hepatosplenomegaly … Abnormalities of liver function tests in thyrotoxicosis. Mil Med. 1978;143:548-551.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - rates of early mortality.14-16 They are
associated with hypertension, heart
disease, stroke, cancer, liver … The damage may be either physical
(e.g., liver damage from chronic drinking) or mental (e.g., depressive … , and breast; liver cirrhosis;
chronic pancreatitis; coronary heart disease; stroke;
depression; preterm … Little evidence was available to determine whether
naltrexone can be used for people with various liver … conditions.b
Future studies could evaluate the use of naltrexone for
people with various chronic liver
-
psnet.ahrq.gov/node/33604/psn-pdf
December 15, 2024 - light of
patient condition, medication list, age, weight,
ethnicity, diet, allergies, and kidney and liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
May 01, 2025 - performed in the United States, with kidney transplants being the most common at 27,000,
followed by liver … an increased risk of death
among patients with a functioning graft.17 In another cohort study with liver … A substantial percentage of liver transplant recipients (~50%) and kidney transplant
recipients (~40% … Association Between Pre-Transplant Oral
Health and Post-Liver Transplant
Complications. … dental
care not of interest
da Silva Santos
2012
Assessment and management of oral health in liver
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.182_slideshow.ppt
September 01, 2008 - Liver and spleen were palpable, the latter extending 6 cm below the left costal margin. … Case C: Part 1—Other Test Results
Test Result
BUN 56 mg/dL
Bilirubin 4.2 mg/dL
AST/GGT (liver
-
hcup-us.ahrq.gov/reports/methods/ComorbiditySoftwareDocumentationFinal.pdf
September 30, 2004 - Liver disease
ICD-9-CM codes: 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 456.0, 456.1,
456.20 … 571.40-571.49, 571.5, 571.6, 571.8, 571.9,
572.3, 572.8, V42.7
Discharge does not have these DRGs: Liver
-
psnet.ahrq.gov/web-mm/failure-reevaluate
February 01, 2014 - , gender, weight, muscle metabolism, and protein intake.( 4 ) Specifically, patients with end-stage liver … Scr may not reflect renal function in patients with reduced muscle mass, malnutrition, and end-stage liver
-
hcup-us.ahrq.gov/reports/natstats/his95/appca.htm
February 11, 2011 - 2.2.2 Cancer of stomach 13 -
2.2.3 Cancer of liver … Secondary malignancy of lung - 1970
2.12.3 Secondary malignancy of liver
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
November 29, 2004 - lipid disorders (LDL > 100 mg/dl, or triglycerides > 200
mg/dl after a minimum 12-hour fast), abnormal liver … patients with relative contraindications to their use—like
renal insufficiency, congestive heart failure, liver … ALT/AST=liver alanine and aspartate transaminase enzyme measurements that reflect liver
status.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
January 12, 2023 - disorders, malabsorptive disorders, celiac disease, cystic fibrosis, short gut syndrome, cholestatic liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - Hypoglycemia
Liver injury
Congestive heart failure
Severe lactic acidosis
Cancer
Severe … Retinopathy
• Nephropathy
• Neuropathy
The outcomes for Key Question 3 are:
• Hypoglycemia
• Liver … □ For Key Question 3, we included the following outcomes: hypoglycemia, liver injury, congestive … □ We included crossover studies for the outcomes of hypoglycemia, liver injury, and GI side effects
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/subglottic-facguide.docx
January 01, 2017 - ICU, and patients involved in high-risk surgical procedures such as thoracic aortic aneurysm repair, liver
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
October 31, 2017 - comorbidity measure: Hypothyroidism 12,927,179 0 0.00 1.00 0.11 0.31
CM_LIVER : AHRQ comorbidity measure: Liver … Tuesday, October 31, 2017 4
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … hemorrhage 92,336 0.71%
254: Other digestive system diagnoses 116,584 0.90%
260: Major pancreas, liver … disorders 41,378 0.32%
280: Alcoholic liver disease 26,398 0.20%
281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
January 01, 2014 - comorbidity measure: Hypothyroidism 14,894,613 0 0.00 1.00 0.10 0.31
CM_LIVER : AHRQ comorbidity measure: Liver … Friday, October 28, 2016 4
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … hemorrhage 105,346 0.71%
254: Other digestive system diagnoses 132,890 0.89%
260: Major pancreas, liver … disorders 46,825 0.31%
280: Alcoholic liver disease 30,408 0.20%
281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
psnet.ahrq.gov/node/49872/psn-pdf
August 08, 2019 - cell count of greater than 30,000 (normal range
4,000–11,000) and was found to be in acute renal and liver … failure with a creatinine of 3.6 mg/dL (normal
range 0.4–1.0 mg/dL) and markedly elevated liver function
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
January 01, 2019 - O.R. 3,760 0.06%
4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 1,663 0.03%
5: LIVER … TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 439 0.01%
6: LIVER TRANSPLANT W/O MCC 139 0.00%
7: LUNG … , LIVER & SHUNT PROCEDURES W/O CC/MCC 201 0.00%
408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W … 947 0.02%
442: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W CC 364 0.01%
442: DISORDERS OF LIVER … EXCEPT MALIG,CIRR,ALC HEPA W CC 1,256 0.02%
443: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W/
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
January 01, 2019 - TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 5,835 0.02%
6: LIVER TRANSPLANT W/O MCC 2,250 0.01%
7: LUNG … & SHUNT PROCEDURES W CC 17,070 0.05%
407: PANCREAS, LIVER & SHUNT PROCEDURES W/O CC/MCC 7,100 0.02% … EXCEPT MALIG,CIRR,ALC HEPA W MCC 46,255 0.13%
442: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA … W CC 14,830 0.04%
442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC 48,565 0.14%
443: DISORDERS … OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W/O CC/MCC 4,005 0.01%
443: DISORDERS OF LIVER EXCEPT MALIG,CIRR
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
March 15, 2013 - No treatment
Outcomes
KQs 2
Labeling, anxiety; harms from liver